Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuncang Zhu

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Thoracic Disease|November 19, 2021
Prognostic value of surgical intervention in advanced lung adenocarcinoma: a population-based studyShuncang Zhu, Tao Ge, Junjie Hu, et al.
Frontiers in Oncology|October 17, 2022
The role of surgery in older patients with T1-2N0M0 small cell lung cancer: A propensity score matching analysisJing Ning, Tao Ge, Shuncang Zhu, et al.
Frontiers in Oncology|July 18, 2022
Surgical Options for Resectable Lung Adenosquamous Carcinoma: A Propensity Score-Matched AnalysisShuncang Zhu, Tao Ge, Yicheng Xiong, et al.
Asia-Pacific Journal of Clinical Oncology|June 14, 2023
Does the number of cycles of neoadjuvant therapy affect the efficacy of neoadjuvant chemoimmunotherapy for non-small cell lung cancer in locally advanced stage? Retrospective experience based on a single centerDi Zhu, Zhida Huang, Kai Xiao, et al.
Bioscience Trends|December 8, 2024
Machine learning-based prognostic prediction and surgical guidance for intrahepatic cholangiocarcinomaLong Huang, Jianbo Li, Shuncang Zhu, et al.
Frontiers in Oncology|December 5, 2022
Development and validation of nomogram prognostic model for early-stage T1-2N0M0 small cell lung cancer: A population-based analysisTao Ge, Shuncang Zhu, Liangdong Sun, et al.
Toxicology and Applied Pharmacology|July 12, 2026
Targeting the JAK-STAT signaling pathway ameliorates chemotherapy-induced skin agingJiandan Li, Zhipeng Luo, Yuanyuan Zheng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 9, 2024
Targeting the MCP-GPX4/HMGB1 Axis for Effectively Triggering Immunogenic Ferroptosis in Pancreatic Ductal AdenocarcinomaGe Li, Chengyu Liao, Jiangzhi Chen, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 28, 2025
Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancerHongyi Lin, Shuncang Zhu, Yinhao Chen, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 21, 2025
Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy and immunotherapyChun Zhang, Yinhao Chen, Shuncang Zhu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Thoracic Disease|November 19, 2021
Prognostic value of surgical intervention in advanced lung adenocarcinoma: a population-based studyShuncang Zhu, Tao Ge, Junjie Hu, et al.
Frontiers in Oncology|October 17, 2022
The role of surgery in older patients with T1-2N0M0 small cell lung cancer: A propensity score matching analysisJing Ning, Tao Ge, Shuncang Zhu, et al.
Frontiers in Oncology|July 18, 2022
Surgical Options for Resectable Lung Adenosquamous Carcinoma: A Propensity Score-Matched AnalysisShuncang Zhu, Tao Ge, Yicheng Xiong, et al.
Asia-Pacific Journal of Clinical Oncology|June 14, 2023
Does the number of cycles of neoadjuvant therapy affect the efficacy of neoadjuvant chemoimmunotherapy for non-small cell lung cancer in locally advanced stage? Retrospective experience based on a single centerDi Zhu, Zhida Huang, Kai Xiao, et al.
Bioscience Trends|December 8, 2024
Machine learning-based prognostic prediction and surgical guidance for intrahepatic cholangiocarcinomaLong Huang, Jianbo Li, Shuncang Zhu, et al.
Frontiers in Oncology|December 5, 2022
Development and validation of nomogram prognostic model for early-stage T1-2N0M0 small cell lung cancer: A population-based analysisTao Ge, Shuncang Zhu, Liangdong Sun, et al.
Toxicology and Applied Pharmacology|July 12, 2026
Targeting the JAK-STAT signaling pathway ameliorates chemotherapy-induced skin agingJiandan Li, Zhipeng Luo, Yuanyuan Zheng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 9, 2024
Targeting the MCP-GPX4/HMGB1 Axis for Effectively Triggering Immunogenic Ferroptosis in Pancreatic Ductal AdenocarcinomaGe Li, Chengyu Liao, Jiangzhi Chen, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 28, 2025
Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancerHongyi Lin, Shuncang Zhu, Yinhao Chen, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 21, 2025
Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy and immunotherapyChun Zhang, Yinhao Chen, Shuncang Zhu, et al.
Pageof 2